NEUROSOV

NeuroSoV is a biotech company focused on the discovery and development of cutting-edge therapies targeted at slowing down neurological disorders. Our first asset targets Parkinson Disease (PD), aiming to deliver the most effective and safe therapeutic solutions to slow-down and treat PD patients, ultimately improving their quality of life... NeuroSoV is committed to operate in an open innovation framework with the highest degree of ethical and integrity practices... Our team is fuelled by the passion to make a difference for patients living with Neurologic/Neurodegenerative Diseases and is comprised of renowned scientists & international experts in the field of Neurosciences, Chemistry, Physics Pharmacology, Medicine and Executives in Business & Economics. NeuroSoV successfully established key strategic partnerships/alliances and active collaborations with both National and International Research Centres and Institutes that position us closer to achieving our objective for patients..